Run-Lin Gao

A randomised comparison of a novel abluminal groove-filled biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent: clinical and angiographic follow-up of the TARGET I trial

• Gao R,
• Xu B,
• Lansky A,
• Yang Y,
• Ma C-S,
• Han Y-L,
• Chen S-L,
• Li H,
• Zhang R,
• Fu G,
• Yuan Z-Y,
• Jiang H,
• Huo Y,
• Li W,
• Zhang Y-J,
• Leon M

EuroIntervention 2013;9:75-83

Published in Volume 9 Number 1, May 2013

A new generation of biodegradable polymer-coated sirolimus-eluting stents for the treatment of coronary artery disease: final 5-year clinical outcomes from the CREATE study

• Han Y-L,
• Zhang L,
• Yang L-X,
• Liu H-L,
• Qu P,
• Li W-M,
• Jiang T-M,
• Li S-M,
• Jing Q-M,
• Zhang Q-Y,
• Xu B,
• Li Y,
• Gao R

EuroIntervention 2012;8:815-822

Published in Volume 8 Number 7, November 2012

Nine-month angiographic and 2-year clinical follow-up of the NOYA biodegradable polymer sirolimus-eluting stent in the treatment of patients with de novo native coronary artery lesions: the NOYA I trial

• Xu B,
• Dou K,
• Yang Y,
• Lv S,
• Wang L,
• Wang H,
• Li Z,
• Wang L,
• Chen Y,
• Huo Y,
• Li W,
• Kirtane A,
• Gao R

EuroIntervention 2012;8:796-802

Published in Volume 8 Number 7, November 2012

Evolution and future perspectives for cardiovascular interventions in China

• Gao R

EuroIntervention 2012;8:773-778

Published in Volume 8 Number 7, November 2012

Outcomes in patients undergoing multivessel percutaneous coronary intervention using sirolimus-eluting stents: a report from the e-SELECT registry

• Cuculi F,
• Banning A,
• Abizaid A,
• Bartorelli A,
• Baux A,
• Dzavik V,
• Ellis SG,
• Gao R,
• Holmes D,
• Jeong M,
• Legrand V,
• Neumann F-J,
• Nyakern M,
• Spaulding C,
• Stoll H-P,
• Worthley S,
• Urban P

EuroIntervention 2011;7:962-968

Published in Volume 7 Number 8, December 2011

The use of Sirolimus-eluting CYPHER Select plus coronary stent in patients with acute myocardial infarction (AMI): 1-year results from the e-SELECT registry

• Spaulding C,
• Manzo-Silberman S,
• Abizaid A,
• Banning A,
• Bartorelli A,
• Dzavik V,
• Ellis SG,
• Gao R,
• Holmes D,
• Jeong M,
• Legrand V,
• Neumann F-J,
• Nyakern M,
• Stoll H-P,
• Worthley S,
• Urban P

Published in Volume 6 Supplement H, May 2010

Stent thrombosis, major bleeding and antiplatelet therapy in the e-SELECT registry: 1-year follow-up of 15,000 patients treated with the Sirolimuseluting CYPHER Select plus stent

• Urban P,
• Abizaid A,
• Banning A,
• Bartorelli A,
• Dzavik V,
• Ellis SG,
• Gao R,
• Holmes D,
• Jeong M,
• Legrand V,
• Neumann F-J,
• Nyakern M,
• Spaulding C,
• Stoll H-P,
• Worthley S

Published in Volume 6 Supplement H, May 2010

The use of CYPHER Select® Plus sirolimus-eluting coronary stents in octogenarian patients: one-year results from e-SELECT registry

• Jeong M-H,
• Hong Y,
• Holmes D,
• Abizaid A,
• Banning A,
• Bartorelli A,
• Ellis SG,
• Gao R,
• Legrand V,
• Neumann F,
• Nyakern M,
• Spaulding C,
• Stoll H,
• Worthley S,
• Urban P

Published in Volume 6 Supplement H, May 2010

The Sirolimus-eluting CYPHER Select plus coronary stent in diabetic patients, 1-year results from the e-SELECT registry

• Bartorelli A,
• Abizaid A,
• Banning A,
• Dzavik V,
• Ellis SG,
• Gao R,
• Holmes D,
• Jeong M,
• Legrand V,
• Neumann F,
• Nyakern M,
• Spaulding C,
• Stoll H,
• Worthley S,
• Urban P

Published in Volume 6 Supplement H, May 2010

The use of the Sirolimus-eluting CYPHER Select plus stent in patients treated for multivessel coronary disease, 1-year results from the e-SELECT registry

• Banning A,
• Abizaid A,
• Bartorelli A,
• Dzavik V,
• Ellis SG,
• Gao R,
• Holmes D,
• Jeong M-H,
• Legrand V,
• Neumann F-J,
• Nyakern M,
• Spaulding C,
• Stoll H-P,
• Worthley S,
• Urban P

Published in Volume 6 Supplement H, May 2010

Outcomes of patients under anti-vitamin K treatment receiving the Sirolimuseluting CYPHER Select plus stent, 1-year results from the e-SELECT registry

• Sabate M,
• Abizaid A,
• Banning A,
• Bartorelli A,
• Dzavik V,
• Ellis SG,
• Gao R,
• Holmes D,
• Jeong M-H,
• Legrand V,
• Neumann F-J,
• Nyakern M,
• Spaulding C,
• Stoll H-P,
• Worthley S,
• Urban P

Published in Volume 6 Supplement H, May 2010

The use of the Sirolimus-eluting CYPHER Select plus coronary stent in patients with renal failure, 1-year results from the e-SELECT registry

• Holmes D,
• Abizaid A,
• Banning A,
• Bartorelli A,
• Dzavik V,
• Ellis SG,
• Gao R,
• Jeong M,
• Legrand V,
• Neumann F-J,
• Nyakern M,
• Spaulding C,
• Stoll H-P,
• Worthley S,
• Urban P

Published in Volume 6 Supplement H, May 2010

First 6 months report from the E-Select registry

• Urban P,
• Banning A,
• Abizaid A,
• Bartorelli A,
• Dzavik V,
• Ellis SG,
• Gao R,
• Holmes D,
• Jeong M,
• Legrand V,
• Neumann F,
• Spaulding C,
• Worthley S

Published in Volume 5 Supplement E, May 2009

PCI and 30-day mortality: the British Columbia PCI risk score

• Hamburger J,
• Walsh S,
• Khurana R,
• Ding L,
• Gao R,
• Humphries K,
• Carere R,
• Fung A,
• Mildenberger R,
• Simkus G,
• Webb J,
• Buller C

Published in Volume 5 Supplement E, May 2009

The use of Sirolimus-eluting Cypher Select stent in diabetic patients: a 6-month report from the e-select registry

• Bartorelli A,
• Abizaid A,
• Banning A,
• Dzavik V,
• Ellis SG,
• Gao R,
• Holmes D,
• Jeong M-H,
• Legrand V,
• Neumann F-J,
• Spaulding C,
• Worthley S,
• Urban P

Published in Volume 5 Supplement E, May 2009